You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-RUNX3 antibody [R3-5G4] (ab40278)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab40278? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab40278 has been referenced in 6 publications.

  1. Yano T et al. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis. Mol Cell Biol 26:4474-88 (2006). PubMed: 16738314
  2. Fu Y et al. RUNX3 Maintains the Mesenchymal Phenotype after Termination of the Notch Signal. J Biol Chem 286:11803-13 (2011). WB; Human. PubMed: 21288908
  3. Goh YM et al. Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm. J Biol Chem 285:10122-9 (2010). WB; Human. PubMed: 20100835
  4. Kodach LL et al. The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer. Carcinogenesis 31:1567-75 (2010). WB; Human. PubMed: 20631058
  5. Sakakura C et al. Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis. Oncogene 26:5927-38 (2007). WB; Human. PubMed: 17384682
  6. Salto-Tellez M et al. RUNX3 protein is overexpressed in human basal cell carcinomas. Oncogene 25:7646-9 (2006). WB; Human. PubMed: 16767156

Publishing research using ab40278? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"